"Navigating the Modern News Zoo so you don't have to."
Friday, June 20, 2025
Targeting fusion protein's role in childhood leukemia produces striking results
Scientists at St. Jude Children's Research Hospital and Dana-Farber Cancer Institute today report the identification of a novel combination therapy approach to treat pediatric acute myeloid leukemia (AML). Standard treatment is often ineffective against AML, a cancer that commonly relapses with poor prognosis, particularly when the disease is fueled by fusion proteins involving NUP98.
👉 Full Story
My guide to picking stocks during market volatility
- Mark Wahlberg Revenge Thriller On Paramount+ Secretly One Of His Best Movies - Jonathan Klotz
- OpenAI and Microsoft Face Legal Action Over Alleged Copyright Violations - Sean George
- Revitalizing Your Android Smartphone: A Comprehensive Guide - Michael A. Medeiros
- New research indicates that dinosaurs got cancer too
- Threads adds new dedicated feed for fediverse content - Andre Revilla
- The 3500 year History of China, the CCP and how GETTR are Making a Stand for Freedom - Diana Zapata
The Wolf-Krugman Exchange: The cost of losing trust in the US | FT Podcasts
- Iranian Dissidents Blast Whoopi's 'Offensive' Take on Life in America Compared to Iran
- Taco Bell's introduces 'first-ever collab' between sweet and spicy with newest menu item
- Dem's Dilemma: What's Good for Blue Staters Is Bad for Red Staters
- Battlestar Galactica Villain's Heel Turn Came Earlier Than Anyone Thought - Chris Snellgrove
- Treehouse Games on how player feedback shaped Voyagers of Nera - Rachel Kaser
- CDC updates COVID vaccine recommendations, but not how RFK Jr. wanted - Beth Mole
